Interaction of 2′,2′-difluorodeoxycytidine (gemcitabine) and formycin b with the Na+-Dependent and -Independent Nucleoside Transporters of Ehrlich Ascites Tumor Cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 3, 1998, Pages 1333-1340

  Burke, Trisha ^a   Ferguson, Peter J ^a   Hammond, James R ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4-NITROBENZYLTHIOINOSINE; ANTINEOPLASTIC ANTIMETABOLITE; CARRIER PROTEIN; DEOXYCYTIDINE; DRUG DERIVATIVE; FORMYCIN B; FORMYCIN DERIVATIVE; GEMCITABINE; MEMBRANE PROTEIN; MERCAPTOPURINE RIBOSIDE; NITROBENZYLTHIOINOSINE; NUCLEOSIDE TRANSPORTER; SODIUM; URIDINE; ADENOSINE; NUCLEOSIDE; NUCLEOSIDE ANALOG; PROTEIN SUBUNIT;

ANIMAL; ARTICLE; EHRLICH ASCITES TUMOR; MALE; METABOLISM; MOUSE; ANIMAL CELL; ANIMAL MODEL; CANCER CHEMOTHERAPY; COMPETITIVE INHIBITION; DOSE RESPONSE; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG UPTAKE; EHRLICH ASCITES TUMOR CELL; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; RECEPTOR AFFINITY; SODIUM CELL LEVEL; TRANSPORT KINETICS;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, EHRLICH TUMOR; CARRIER PROTEINS; DEOXYCYTIDINE; FORMYCINS; MALE; MEMBRANE PROTEINS; MICE; NUCLEOSIDE TRANSPORT PROTEINS; SODIUM; THIOINOSINE; URIDINE;

EID: 0032161652     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Baer HP and Moorji A (1990) Sodium-dependent and inhibitor-insensitive uptake of adenosine by mouse peritoneal exudate cells. Biochim Biophys Acta Bio-Membr 1026:241-247.
2. Baer HP, Moorji A, Ogbunude POJ and Serignese V (1992) Sodium-dependent nucleoside transport in mouse lymphocytes, human monocytes, and hamster macrophages and peritoneal exudate cells. Can J Physiol Pharmacol 70:29-35.
3. Belt JA, Marina NM, Phelps DA and Crawford CR (1993) Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul 33:235-252.
4. 3H]Formycin B via sodium-dependent nucleoside transporters in mouse leukemic L1210/MA27.1 cells. J Pharmacol Exp Ther 281:347-353.
5. Cass CE (1995) Nucleoside transport, in Drug Transport in Antimicrobial Therapy and Anticancer Therapy (Georgopapadakou NH ed) pp 403-452, Marcel Dekker, New York.
6. Conant AR and Jarvis SM (1994) Nucleoside influx and efflux in guinea-pig ventricular myocytes. Inhibition by analogues of lidoflazine. Biochem Pharmacol 48:873-880.
7. Crawford CR and Belt JA (1991) Sodium-dependent, concentrative nucleoside transport in Walker 256 rat carcinosarcoma cells. Biochem Biophys Res Commun 175:846-851.
8. Crawford CR, Ng CYC, Noel LD and Belt JA (1990) Nucleoside transport in L1210 murine leukemia cells. Evidence for three transporters. J Biol Chem 265:9732-9736.
9. Dagnino L and Paterson ARP (1990) Sodium-dependent and equilibrative nucleoside transport systems in L1210 mouse leukemia cells: Effect of inhibitors of equilibrative systems on the content and retention of nucleosides. Cancer Res 50:6549-6553.
10. Dagnino L, Bennett Jr LL and Paterson ARP (1991) Sodium-dependent nucleoside transport in mouse leukemia L1210 cells. J Biol Chem 266:6308-6311.
11. + -dependent and -independent uridine uptake in an established renal epithelial cell line, OK, from the opossum kidney. Biochim Biophys Acta Bio-Membr 1147:214-222.
12. rat) by transient expression in cultured mammalian cells. Biochem J 317:457-465.
13. Griffith DA, Conant AR and Jarvis SM (1990) Differential inhibition of nucleoside transport systems in mammalian cells by a new series of compounds related to lidoflazine and mioflazine. Biochem Pharmacol 40:2297-2303.
14. Griffith DA and Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta Reu Biomembr 1286:153-181.
15. Griffiths M, Beaumont N, Yao SYM, Sundaram M, Boumah CE, Davies A, Kwong FYP, Coe I, Cass CE, Young JD and Baldwin SA (1997) Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med 3:89-93.
16. Guchelaar HJ, Richel DJ and Van Knapen A (1996) Clinical, lexicological and pharmacological aspects of gemcitabine. Cancer Treat Rev 22:15-31.
17. 3H)ni-
18. trobenzylthioinosine to the nucleoside transport system in mammalian central nervous system membranes: Evidence for interconvertible conformations of the binding site/transporter complex. J Neurochem 45:527-535.
19. Hammond JR and Johnstone RM (1989) Solubilization and reconstitution of a nucleoside-transport system from Ehrlich ascites-tumour cells. Biochem J 262: 109-118.
20. Hammond JR (1991) Comparative pharmacology of the nitrobenzylthioguanosinesensitive and -resistant nucleoside transport mechanisms of Ehrlich ascites tumor cells. J Pharmacol Exp Ther 259:799-807.
21. 3H]guanosine by nucleoside transporter subtypes in Ehrlich ascites tumour cells. Biochem J 287:431-436.
22. Hui YF and Reitz J (1997) Gemcitabine: A cytidine analogue active against solid tumors. Am J Health Syst Pharm 54:162-170.
23. Jacobson KA, Van Galen PJM and Williams M (1992) Adenosine receptors: Pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 35:407-422.
24. Jakobs ES and Paterson AR (1986) Sodium dependent, concentrative nucleoside transport in cultured intestinal epithelial cells. Biochem Biophys Res Commun 140:1028-1035.
25. Jansen WJM, Pinedo HM, Van Der Wilt CL, Feller N, Bamberger U and Boven E (1995) The influence of BIEW22BS, a dipyridamole derivative, on the antiproliferative effects of !5-fluorouracil, methotrexate and gemcitabine in vitro and in human tumour xenografts. EUT J Cancer [A] 31A:2313-2319.
26. Jarvis SM (1986) Trans-stimulation and (rans-inhibition of uridine efflux from human erythrocytes by permeant nucleosides. Biochem J 233:295-297.
27. Jarvis SM (1989) Characterization of sodium-dependent nucleoside transport in rabbit intestinal brush-border membrane vesicles. Biochim Biopfiys Acta 979:132-138.
28. Moore M (1996) Activity of gemcitabine in patients with advanced pancreatic carcinoma-A review. Cancer 78:633-638.
29. Ogbunude POJ and Baer HP (1990) Competition of nucleoside transport inhibitors with binding of 6-[(4-nitrobenzyl)-mercapto]purine ribonucleoside to intact er/throcytes and ghost membranes from different species. Biochem Pharmacol 39: 1199-1204.
30. Parkinson FE and Geiger JD (1996) Effects of iodotubercidin on adenosine khiase activity and nucleoside transport in DDTjMF-2 smooth muscle cells. J Pharmacol Exp Ther 277:1397-1401.
31. Paterson AK, Gati WP, Vijayalakshmi D, Cass CE, Mant MJ, Young JD and Bolch AR (1993) Inhibitor-sensitive, Na-linked transport of nucleoside analogs in .eukemia cells from patients (Abstract). Proc Am Assoc Cancer Res 34:14.
32. Phillis JW (1991) Adenosine and Adenine Nucleotides as Regulators of Cellvlar Function, CRC Press, Ann Arbor, MI.
33. Plagemann PGW and Aran JM (1990) Na +-dependent, active nucleoside transport in mouse spleen lymphocytes, leukemia cells, fibroblasts and macrophages, but not in equivalent human or pig cells; dipyridamole enhances nucleoside salvage by cells with both active and facilitated transport. Biochim Biophys Acta Bio-Menbr 1025:32-42.
34. Plagemann PGW and Aran JM (1990) Characterization of Na+-dependent, active nucleoside transport in rat and mouse peritoneal macrophages, a mouse macrophage cell line and normal rat kidney cells. Biochim Biophys Acta Bio-Mer.ibr 1028:289-298.
35. Plagemann PGW and Woffendin C (1988) Species differences in sensitivity of nudeoside transport in erythrocytes and cultured cells to inhibition by nitrobenzylthioinosine, dipyridamole, dilazep, and lidoflazine. Biochim Biophys Acta 969:1-8.
36. Plagemann PGW and Woffendin C (1989) Use of formycin B as a general substrate for measuring facilitated nucleoside transport in mammalian cells. Biochim Biophys Acta 1010:7-15.
37. Plagemann PGW, Aran JM and Woffendin C (1990) Na+-dependent, active find Na +-independent, facilitated transport of formycin B in mouse spleen lymphocytes. Biochim Biophys Acta 1022:93-102.
38. Plunkett W, Huang P and Gandhi V (1995) Preclinical characteristics of gemcitabine. Anti-Cancer Drugs 6:7-13.
39. Roden M, Paterson ARP and Turnheim K (1991) Sodium-dependent nucleoside transport in rabbit intestinal epithelium. Gastroenterology 100:1553-1562.
40. Rongen GA, Floras JS, Lenders JWM, Thien T and Smits P (1997) Cardiovascular pharmacology of purines. Clin Sei 92:13-24.
41. Roovers KI and Meckling-Gill KA (1996) Characterization of equilibrative and concentrative Na + -dependent (cif) nucleoside transport in acute promyelocytic leukemia NB4 cells. J Cell Physiol 166:593-600.
42. Ross DD and Cuddy DP (1994) Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells. Biochem Pharmacol 48:16191630.
43. Shank RP and Baldy WJ (1990) Adenosine transport by rat and guinea pig synuptosomes: Basis for differential sensitivity to transport inhibitors. J Neurochem 55:541-550.
44. Shewach DS and Lawrence TS (1995) Radiosensitization of human tumor cells by gemcitabine in vitro. Semin Oncol 22:68-71.
45. Spector R and Huntoon S (1984) Specificity and sodium dependence of the active nucleoside transport system in choroid plexus. JNeurochem 42:1048-1052.
46. Vijayalakshmi D and Belt JA (1988) Sodium-dependent nucleoside transport in mouse intestinal epithelial cells. Two transport systems with differing substrate specificities. J Biol Chem 263:19419-19423.
47. Williams M (1987) Purine receptors in mammalian tissues: Pharmacology and functional significance. Annu Rev Pharmacol Toxicol 27:315-345.
48. Williams M (1989) Adenosine: The prototypic neuromodulator. Neurochem Int ]4: 249-264.
49. Williams TC, Doherty AJ, Griffith DA and Jarvis SM (1989) Characterization of sodium-dependent and sodium-independent nucleoside transport systems in rabbit brush-border and basolateral plasma-membrane vesicles from the renal outer cortex. Biochem J 264:223-231.
50. Williams TC and Jarvis SM (1991) Multiple sodium-dependent nucleoside transport systems in bovine renal brush-border membrane vesicles. Biochem J 274:27-33.